Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Bellerophon Therapeutics: Q2 Earnings Insights

  Bellerophon Therapeutics (NASDAQ:BLPH) reported its Q2 earnings results on Monday, August 15, 2022 at 08:00 AM. Here's what investors need to know about the announcement. Earnings Bellerophon Therapeutics reported an EPS of $-0.43.
byBenzinga Insights
August 15, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

 

Bellerophon Therapeutics (NASDAQ:BLPH) reported its Q2 earnings results on Monday, August 15, 2022 at 08:00 AM.

Here’s what investors need to know about the announcement.

Earnings

Bellerophon Therapeutics reported an EPS of $-0.43.

Revenue was down $0 from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.05 which was followed by a 2.72% increase in the share price the next day.

 

Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for Bellerophon Therapeutics visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Recap: Avinger Q1 Earnings

By Benzinga Insights
Today, 4:11 PM
Avinger (NASDAQ:AVGR) reported its Q1 earnings results on Tuesday, May 10, 2022 at 04:01 PM. Here's what investors need to know about the announcement. Earnings Avinger missed estimated earnings by 99.15%, reporting an EPS of $-2.33 versus an estimate of $-1.17.

AVGR